Eli Lilly has taken a significant step towards making weight loss medications more accessible by reducing the price of their ...

Eli Lilly, Johnson & Johnson and Sanofi stay in focus as Big Pharma shows signs of recovery amid innovation, M&A and easing ...

Get the latest stock market and healthcare sector updates, top gainers and losers, and key regulatory news impacting investments.

The first strong outlook factor for IHE is its inclusion of Eli Lilly at almost 27% weight. The pharmaceutical company has seen tremendous growth due to Mounjaro, approved by the FDA in 2022, and ...

Novo Nordisk, Eli Lilly call their diabetes and weight loss drugs “safe and effective” as they face accusations in lawsuits ...

A lawsuit from the American Hospital Association and others seeks to block the Trump administration's new 340B Rebate Model ...

Marketers are positioning weight-loss shots as cosmetic elixirs for anyone who wants to lose a few pounds. Doctors warn that such patients could put themselves at risk for potentially serious side ...

Bristol Myers Squibb said it will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer’s disease, after the company found “irregularities due to ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

Telehealth companies are aggressively marketing GLP-1s as cosmetic elixirs for anyone who wants to lose a few pounds.

Project: Strive Pharmacy has broken ground on a new 350,000-square-foot facility in Mesa, AZ, which will serve as its new ...

Eli Lilly will cut prices for its weight loss drug Zepbound, with single-dose vials now available for $299 per month through ...